InsiderClue
Stocks · Health care · In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics, Inc.

CLDX Clue Score15
United States Fiscal year ends December CIK 0000744218 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
Samuel Bates Martin
2 Jan 2026
SVP and CFO
Exercised, kept
4,817
$10.38
$50.00K
Ronald Pepin
15 Dec 2025
Sr. VP & Cbo
Exercised, kept
11,000
$2.78
$30.58K
Ronald Pepin
15 Dec 2025
Sr. VP & Cbo
Exercised, kept
8,333
$9.02
$75.13K
Diane C. Young
11 Jun 2024
SVP, Chief Medical Officer
Exercised, kept
15,000
$2.71
$40.65K
Freddy A. Jimenez
5 Jun 2024
SVP & General Counsel
Exercised, kept
9,540
$10.38
$99.03K
Freddy A. Jimenez
13 Feb 2024
SVP & General Counsel
Exercised, kept
20,000
$2.78
$55.60K
Freddy A. Jimenez
13 Feb 2024
SVP & General Counsel
Exercised, kept
4,166
$9.02
$37.56K
Samuel Bates Martin
2 Jan 2024
SVP and CFO
Exercised, kept
10,750
$2.78
$29.89K
Margo Heath-Chiozzi
11 Aug 2021
SVP of Regulatory Affairs
Exercised, kept
10,000
$9.02
$90.17K
Anthony S Marucci
5 Aug 2021
President & CEO
Exercised, kept
3,537
$42.00
$148.55K
Show all 65 transactions →

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 40
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 1,008,121
History held since 8 Jan 2007